Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew S Bomback

Showing results (51-60 of 200) with videos related to

Pageof 20
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|March 11, 2020
The Evolving Role of Calcineurin Inhibitors in Treating Lupus NephritisYonatan Peleg, Andrew S Bomback, Jai Radhakrishnan
Kidney International Reports|January 15, 2025
Challenges in the Diagnosis and Management of Immune Complex-Mediated Membranoproliferative Glomerulonephritis and Complement 3 GlomerulopathyAndrew S Bomback, Vivek Charu, Fadi Fakhouri
Kidney International Reports|April 18, 2019
Rituximab for Anti-Glomerular Basement Membrane DiseaseRashmi Jain, Hanna Dgheim, Andrew S Bomback
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 28, 2021
De Novo and Relapsing Glomerular Diseases After COVID-19 Vaccination: What Do We Know So Far?Andrew S Bomback, Satoru Kudose, Vivette D D'Agati
Advances in Kidney Disease and Health|July 14, 2024
Update on C3 GlomerulopathyBenjamin Wooden, Carla M Nester, Andrew S Bomback
Seminars in Nephrology|July 14, 2014
Aldosterone blockade in chronic kidney diseaseJamie S Hirsch, Yelena Drexler, Andrew S Bomback
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 1, 2026
Complement 3 Glomerulopathy (C3G) in Native and Posttransplant Kidneys: Pathophysiology, Prognosis, and TreatmentManuel Praga, Richard J Smith, Andrew S Bomback
Sports Medicine (Auckland, N.Z.)|August 28, 2024
High Protein Diets and Glomerular Hyperfiltration in Athletes and Bodybuilders: Is Chronic Kidney Disease the Real Finish Line?Alberto de Lorenzo, Andrew S Bomback, Niko Mihic
Current Hypertension Reports|April 6, 2011
Mineralocorticoid receptor blockade in chronic kidney diseaseMatthew J Volk, Andrew S Bomback, Philip J Klemmer
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|May 10, 2007
Of snakes and men: the evolution of ACE inhibitorsAndrew S Bomback, Riley M Bove, Philip J Klemmer
Pageof 20

Showing results (51-60 of 200) with videos related to

Sort By:
Pageof 20
Clinical Journal of the American Society of Nephrology : CJASN|March 11, 2020
The Evolving Role of Calcineurin Inhibitors in Treating Lupus NephritisYonatan Peleg, Andrew S Bomback, Jai Radhakrishnan
Kidney International Reports|January 15, 2025
Challenges in the Diagnosis and Management of Immune Complex-Mediated Membranoproliferative Glomerulonephritis and Complement 3 GlomerulopathyAndrew S Bomback, Vivek Charu, Fadi Fakhouri
Kidney International Reports|April 18, 2019
Rituximab for Anti-Glomerular Basement Membrane DiseaseRashmi Jain, Hanna Dgheim, Andrew S Bomback
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 28, 2021
De Novo and Relapsing Glomerular Diseases After COVID-19 Vaccination: What Do We Know So Far?Andrew S Bomback, Satoru Kudose, Vivette D D'Agati
Advances in Kidney Disease and Health|July 14, 2024
Update on C3 GlomerulopathyBenjamin Wooden, Carla M Nester, Andrew S Bomback
Seminars in Nephrology|July 14, 2014
Aldosterone blockade in chronic kidney diseaseJamie S Hirsch, Yelena Drexler, Andrew S Bomback
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 1, 2026
Complement 3 Glomerulopathy (C3G) in Native and Posttransplant Kidneys: Pathophysiology, Prognosis, and TreatmentManuel Praga, Richard J Smith, Andrew S Bomback
Sports Medicine (Auckland, N.Z.)|August 28, 2024
High Protein Diets and Glomerular Hyperfiltration in Athletes and Bodybuilders: Is Chronic Kidney Disease the Real Finish Line?Alberto de Lorenzo, Andrew S Bomback, Niko Mihic
Current Hypertension Reports|April 6, 2011
Mineralocorticoid receptor blockade in chronic kidney diseaseMatthew J Volk, Andrew S Bomback, Philip J Klemmer
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|May 10, 2007
Of snakes and men: the evolution of ACE inhibitorsAndrew S Bomback, Riley M Bove, Philip J Klemmer
Pageof 20